Drug Profile
VCN 11
Alternative Names: VCN-11Latest Information Update: 22 Nov 2022
Price :
$50
*
At a glance
- Originator VCN Biosciences
- Class Antineoplastics; Gene therapies; Oncolytic viruses
- Mechanism of Action Cell death stimulants; Hyaluronidase stimulants; Immunologic cytotoxicity
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours